Price $32.95 |
Market Cap
196.52B
|
Sector Health Care |
Div. Growth
-14.10%
|
|
P/E
27.8
|
P/B
3.41
|
P/S
3.79
|
Dividend %
3.90%
|
|
P/CF
78.7
|
P/FCF
16.6
|
Op. Cash Flow
14.03M
|
FCF
2.0
|
|
Op. Margin
18.00%
|
Net Margin
13.90%
|
ROE
12.00%
|
ROI
7.80%
|
|
ROA
4.20%
|
EPS Growth
-25.30%
|
Current Ratio
1.3
|
Debt/Equity
52.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Xtant Medical Holdings Inc (XTNT) | $0.65 | - | - | 13.5M | Strong Buy |
| STRATA Skin Sciences Inc (SSKN) | $1.63 | - | - | 4.8M | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.22 | - | - | 31.1M | Strong Buy |
| iCAD Inc (ICAD) | $3.63 | - | - | 64.7M | Strong Buy |
| Enzon Pharmaceuticals Inc (ENZN) | $0.38 | - | - | 17.2M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
